ZNG-11823-88271
2 vaccinations
4 coded responses
15 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 120 / NY
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-07
Dose 1 — Moderna
-
2021-01-13
Registered in v-safe
-
2021-01-13
Survey response — days 1–6 daily, dose 1MedDRA: Dyspnoea, Tachycardia — Feeling: Poor · Site: Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Tachycardia, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Survey response — day 7, dose 1MedDRA: Dyspnoea, Tachycardia — Feeling: Good · Joint pains, Muscle or body aches, Nausea, Abdominal painFree text: Tachycardia, shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-30
- 2021-02-04
-
2021-02-05
Dose 2 — Moderna
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-12
Health check-in — day 7, dose 2Feeling: Fair · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-05-07
-
2021-08-06
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: FairFree text: PregnantMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-05
Survey response — 12 months, dose 2MedDRA: Postpartum state, Pre-eclampsia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Postpartum preeclampsiaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-05 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Tachycardia, shortness of breath
Release 1 — day 7, dose 1
Systemic reaction (other): Tachycardia, shortness of breath
Release 9 — 6 months, dose 2
Symptoms: Pregnant
Release 11 — 12 months, dose 2
Symptoms: Postpartum preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Postpartum state | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release